Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Pharmac won't drop low-ranked medicines from its funding list after public outcry over equity and access concerns.

flag Pharmac has scrapped plans to remove low-ranked medicines from its Options for Investment list after widespread opposition from patients, advocates, and communities. flag Concerns centered on equity, particularly for Māori, Pacific peoples, rural populations, and those with rare disorders, as well as the importance of maintaining hope for future funding. flag The agency confirmed it will not implement the change, emphasizing its ongoing commitment to transparency and timeliness through its Reset Programme. flag Public input will continue to shape future decisions.

3 Articles

Further Reading